Our team

Korro Bio was founded to turn extraordinary scientific insights into life-altering new treatments for patients. We harness the body’s natural RNA editing machinery to make precise, single-base RNA edits to modulate protein function, addressing the medical needs of patients. Our mission is to rewrite the future for patients living with debilitating disease by repairing the underlying genetic cause.

Korro Bio’s team of experts is working to overcome the challenges that have limited existing gene editing and gene therapy approaches, and treat diseases that have previously been unreachable by other methods.

Management

  • Ram Aiyar, Ph.D., MBA

    Ram Aiyar, Ph.D., MBA

    CHIEF EXECUTIVE OFFICER

    READ RAM'S BIO
  • Anna Barry, Ph.D., J.D.

    Anna Barry, Ph.D., J.D.

    CHIEF LEGAL OFFICER & HEAD OF CORPORATE STRATEGY

    READ ANNA’S BIO
  • Andrew Fraley, Ph.D.

    Andrew Fraley, Ph.D.

    CO-FOUNDER & CHIEF TECHNOLOGY OFFICER

    READ ANDREW’S BIO
  • Yong Chang, Ph.D.

    Yong Chang, Ph.D.

    SVP, DEVELOPMENT

    READ YONG’S BIO
  • Stuart Milstein, Ph.D.

    Stuart Milstein, Ph.D.

    VP, PLATFORM BIOLOGY

    READ STUART’S BIO

Founders

  • Jean-François Formela, M.D.

    Jean-François Formela, M.D.

    CO-FOUNDER & DIRECTOR

    READ JEAN-FRANCOIS’S BIO
  • Josh Rosenthal, Ph.D.

    Josh Rosenthal, Ph.D.

    CO-FOUNDER & PROF MBL, ADAR BIO

    READ JOSH’S BIO
  • Nessan Bermingham, Ph.D.

    Nessan Bermingham, Ph.D.

    CO-FOUNDER & EXECUTIVE CHAIRMAN

    READ NESSAN’S BIO
  • Andrew Fraley, Ph.D.

    Andrew Fraley, Ph.D.

    CO-FOUNDER & CHIEF TECHNOLOGY OFFICER

    READ ANDREW’S BIO

Board of Directors

  • Nessan Bermingham, Ph.D.

    CO-FOUNDER & EXECUTIVE CHAIRMAN

    READ NESSAN’S BIO
  • Jean-François Formela, M.D.

    CO-FOUNDER & DIRECTOR

    READ JEAN-FRANCOIS’S BIO
  • Ali Behbahani, M.D.

    DIRECTOR

    READ ALI’S BIO
  • Hannah H. Chang, M.D., Ph.D.

    DIRECTOR

    READ HANNAH’S BIO
  • Colin Walsh, Ph.D.

    DIRECTOR

    READ COLIN’S BIO
  • Omar Khwaja, M.D., Ph.D.

    DIRECTOR

    READ OMAR’S BIO

Investors

We are thrilled to have the support of some of biotech’s top investors as we establish a leading position in RNA editing.